154 related articles for article (PubMed ID: 34857676)
1. S-nitrosothiols signaling in cystic fibrosis airways.
Liu M; Zaman R; Sawczak V; Periasamy A; Sun F; Zaman K
J Biosci; 2021; 46():. PubMed ID: 34857676
[TBL] [Abstract][Full Text] [Related]
2. Novel s-nitrosothiols have potential therapeutic uses for cystic fibrosis.
Zaman K; Fraser-Butler M; Bennett D
Curr Pharm Des; 2013; 19(19):3509-20. PubMed ID: 23331028
[TBL] [Abstract][Full Text] [Related]
3.
Zaman K; Knight J; Hussain F; Cao R; Estabrooks SK; Altawallbeh G; Holloway K; Jafri A; Sawczak V; Li Y; Getsy P; Sun F; Raffay T; Cotton C; Brodsky JL; Periasamy A; Lewis SJ; Gaston B
Am J Respir Cell Mol Biol; 2019 Dec; 61(6):765-775. PubMed ID: 31596601
[No Abstract] [Full Text] [Related]
4. S-Nitrosothiols increases cystic fibrosis transmembrane regulator expression and maturation in the cell surface.
Zaman K; Bennett D; Fraser-Butler M; Greenberg Z; Getsy P; Sattar A; Smith L; Corey D; Sun F; Hunt J; Lewis SJ; Gaston B
Biochem Biophys Res Commun; 2014 Jan; 443(4):1257-62. PubMed ID: 24393850
[TBL] [Abstract][Full Text] [Related]
5. Novel Approaches for Potential Therapy of Cystic Fibrosis.
Sawczak V; Getsy P; Zaidi A; Sun F; Zaman K; Gaston B
Curr Drug Targets; 2015; 16(9):923-36. PubMed ID: 25557257
[TBL] [Abstract][Full Text] [Related]
6. Augmentation of CFTR maturation by S-nitrosoglutathione reductase.
Zaman K; Sawczak V; Zaidi A; Butler M; Bennett D; Getsy P; Zeinomar M; Greenberg Z; Forbes M; Rehman S; Jyothikumar V; DeRonde K; Sattar A; Smith L; Corey D; Straub A; Sun F; Palmer L; Periasamy A; Randell S; Kelley TJ; Lewis SJ; Gaston B
Am J Physiol Lung Cell Mol Physiol; 2016 Feb; 310(3):L263-70. PubMed ID: 26637637
[TBL] [Abstract][Full Text] [Related]
7. HGF stimulation of Rac1 signaling enhances pharmacological correction of the most prevalent cystic fibrosis mutant F508del-CFTR.
Moniz S; Sousa M; Moraes BJ; Mendes AI; Palma M; Barreto C; Fragata JI; Amaral MD; Matos P
ACS Chem Biol; 2013 Feb; 8(2):432-42. PubMed ID: 23148778
[TBL] [Abstract][Full Text] [Related]
8. Unravelling the Regions of Mutant F508del-CFTR More Susceptible to the Action of Four Cystic Fibrosis Correctors.
Amico G; Brandas C; Moran O; Baroni D
Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31683989
[TBL] [Abstract][Full Text] [Related]
9. ORKAMBI-Mediated Rescue of Mucociliary Clearance in Cystic Fibrosis Primary Respiratory Cultures Is Enhanced by Arginine Uptake, Arginase Inhibition, and Promotion of Nitric Oxide Signaling to the Cystic Fibrosis Transmembrane Conductance Regulator Channel.
Wu YS; Jiang J; Ahmadi S; Lew A; Laselva O; Xia S; Bartlett C; Ip W; Wellhauser L; Ouyang H; Gonska T; Moraes TJ; Bear CE
Mol Pharmacol; 2019 Oct; 96(4):515-525. PubMed ID: 31427400
[TBL] [Abstract][Full Text] [Related]
10. Augmentation of Cystic Fibrosis Transmembrane Conductance Regulator Function in Human Bronchial Epithelial Cells via SLC6A14-Dependent Amino Acid Uptake. Implications for Treatment of Cystic Fibrosis.
Ahmadi S; Wu YS; Li M; Ip W; Lloyd-Kuzik A; Di Paola M; Du K; Xia S; Lew A; Bozoky Z; Forman-Kay J; Bear CE; Gonska T
Am J Respir Cell Mol Biol; 2019 Dec; 61(6):755-764. PubMed ID: 31189070
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological Correction of Cystic Fibrosis: Molecular Mechanisms at the Plasma Membrane to Augment Mutant CFTR Function.
Arora K; Naren AP
Curr Drug Targets; 2016; 17(11):1275-81. PubMed ID: 26648081
[TBL] [Abstract][Full Text] [Related]
12. Correctors (specific therapies for class II CFTR mutations) for cystic fibrosis.
Southern KW; Patel S; Sinha IP; Nevitt SJ
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD010966. PubMed ID: 30070364
[TBL] [Abstract][Full Text] [Related]
13. Two Small Molecules Restore Stability to a Subpopulation of the Cystic Fibrosis Transmembrane Conductance Regulator with the Predominant Disease-causing Mutation.
Meng X; Wang Y; Wang X; Wrennall JA; Rimington TL; Li H; Cai Z; Ford RC; Sheppard DN
J Biol Chem; 2017 Mar; 292(9):3706-3719. PubMed ID: 28087700
[TBL] [Abstract][Full Text] [Related]
14. Restoration of CFTR function in patients with cystic fibrosis carrying the F508del-CFTR mutation.
De Stefano D; Villella VR; Esposito S; Tosco A; Sepe A; De Gregorio F; Salvadori L; Grassia R; Leone CA; De Rosa G; Maiuri MC; Pettoello-Mantovani M; Guido S; Bossi A; Zolin A; Venerando A; Pinna LA; Mehta A; Bona G; Kroemer G; Maiuri L; Raia V
Autophagy; 2014; 10(11):2053-74. PubMed ID: 25350163
[TBL] [Abstract][Full Text] [Related]
15. VX-809 corrects folding defects in cystic fibrosis transmembrane conductance regulator protein through action on membrane-spanning domain 1.
Ren HY; Grove DE; De La Rosa O; Houck SA; Sopha P; Van Goor F; Hoffman BJ; Cyr DM
Mol Biol Cell; 2013 Oct; 24(19):3016-24. PubMed ID: 23924900
[TBL] [Abstract][Full Text] [Related]
16. Osteoclastogenesis and sphingosine-1-phosphate secretion from human osteoclast precursor monocytes are modulated by the cystic fibrosis transmembrane conductance regulator.
Jourdain ML; Sergheraert J; Braux J; Guillaume C; Gangloff SC; Hubert D; Velard F; Jacquot J
Biochim Biophys Acta Mol Basis Dis; 2021 Mar; 1867(3):166010. PubMed ID: 33188942
[TBL] [Abstract][Full Text] [Related]
17. [Pulmonary metabolism of nitric oxide (NO) in patients with cystic fibrosis].
Grasemann H; Ratjen F
Pneumologie; 2002 Jun; 56(6):376-81. PubMed ID: 12063621
[TBL] [Abstract][Full Text] [Related]
18. Measurements of Functional Responses in Human Primary Lung Cells as a Basis for Personalized Therapy for Cystic Fibrosis.
Awatade NT; Uliyakina I; Farinha CM; Clarke LA; Mendes K; Solé A; Pastor J; Ramos MM; Amaral MD
EBioMedicine; 2015; 2(2):147-53. PubMed ID: 26137539
[TBL] [Abstract][Full Text] [Related]
19. New horizons in the treatment of cystic fibrosis.
Cuthbert AW
Br J Pharmacol; 2011 May; 163(1):173-83. PubMed ID: 21108631
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of the Chaperone-Like HspB5 Rescues Trafficking and Function of F508del-CFTR.
Degrugillier F; Aissat A; Prulière-Escabasse V; Bizard L; Simonneau B; Decrouy X; Jiang C; Rotin D; Fanen P; Simon S
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32650630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
